Navigation Links
Marrone Bio Innovations Establishes International Science Advisory Panel
Date:11/20/2013

DAVIS, Calif., Nov. 20, 2013 /PRNewswire/ -- Marrone Bio Innovations, Inc. (MBI) [NASDAQ: MBII], a leading global provider of bio-based pest management and plant health products, announced the establishment of an International Science Advisory Panel (ISAP). Emeritus Professor Alison Stewart, MBI Chief Science Officer, explains its mission, "MBI believes it is essential to have rigorous external critique of our strategic and operational framework. The ISAP will provide a powerful vehicle for driving innovation and it will enable us to keep a pulse on the global biopesticide research landscape and stay at the leading edge of this burgeoning industry."

(Logo: http://photos.prnewswire.com/prnh/20130814/SF63633LOGO)

The panel is comprised of recognized leading authorities in a variety of scientific disciplines. Their broad expertise will be key in fulfilling the panel's role to provide strategic advice on R&D approaches and directions, offer technical input on new technologies and give critical commentary on global opportunities and threats in the biopesticide area.

Members of the International Science Advisory Panel and their areas of expertise are:

  • Professor Lodovica Gullino—Director Agroinnova, University of Torino, Italy; plant disease biocontrol.
  • Professor Gabriele Berg—Graz University of Technology, Austria; microbiology.
  • Professor Emeritus Richard A. Sikora —University of Bonn, Germany; nematology.
  • Dr. Trevor Jackson—AgResearch, New Zealand; entomology.
  • Emeritus Professor Roberta L. Farrell—University of Waikato, New Zealand; biochemistry.
  • Professor William Fenical—University of California, San Diego, USA; natural product chemistry.
  • Alan Knowles—Director & Principal Consultant, FORM-AK Ltd, UK; formulation science and technology.
  • Professor Orlando J. Rojas—North Carolina State University, USA; formulation engineering.
  • Emeritus Professor Baruch Rubin—Hebrew University of Jerusalem, Israel; weed science.
  • Professor Dr. Henk Noorman—DSM Biotechnology Center, The Netherlands; bioprocessing technology.

Additional information about the ISAP panel members can be found on the Marrone Bio Innovations website, www.marronebio.com.

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
2. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
3. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
4. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
5. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
6. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
7. Nanoantennas show promise in optical innovations
8. ARUP Laboratories Announces Creation of Business Innovations Division
9. 2012 Hannover Messe: Innovations by KIT
10. Air Innovations’ Environmental Control Projects Featured in Trade Media
11. Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. ... editing, announced today that Edward Lanphier , Sangamo,s ... on the progress of Sangamo,s ZFP Therapeutic ® ... strategy at 2:40 pm ET on Thursday, February 11, ... Global Healthcare Conference. The conference is being held in ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... 4, 2016 --> ... company is pleased to provide the following update on recent ... Over the last 3 months we have significantly increased our ... exceeding $1,000,000. As a result, we have positioned ourselves to ... license agreement and expect that development to continue on schedule. ...
(Date:2/4/2016)... 4, 2016 Sinovac Biotech Ltd. ("Sinovac" or ... of biopharmaceutical products in China , ... of directors received on February 4, 2016 a preliminary ... consortium comprised of PKU V-Ming ( Shanghai ... CICC Qianhai Development ( Shenzhen ) Fund ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/28/2016)... (NASDAQ: SYNA ), a leading developer of human interface solutions, ... 2015. --> --> Net ... compared to the comparable quarter last year to $470.5 million. Net ... or $0.93 per diluted share. --> ... fiscal 2016 grew 9 percent over the prior year period to ...
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
Breaking Biology News(10 mins):